Opioid and progesterone signaling is obligatory for early human embryogenesis

Stem Cells and Development

Volumn 18, Issue 5, 2009, Pages 737-740

  Gallego, Miguel J ^a   Porayette, Prashob ^a   Kaltcheva, Maria M ^a   Meethal, Sivan Vadakkadath ^a   Atwood, Craig S ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NESTIN; OPIATE; PROGESTERONE;

ARTICLE; BLASTOCYST; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GERM LAYER; HUMAN; HUMAN CELL; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANALGESICS, OPIOID; ANIMALS; CELL DIFFERENTIATION; CELL LINE; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENKEPHALIN, LEUCINE; HUMANS; MICE; MIFEPRISTONE; NEURAL PLATE; PROGESTERONE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 66249138810     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0190     Document Type: Article

References (15)

1. Zhuang LZ and RH Li. (1991). Study on reproductive endocrinology of human placenta (II) - hormone secreting activity of cytotrophoblast cells. Sci China B 34:1092-1097.
2. DiPirro JM and MB Kristal. (2004). Placenta ingestion by rats enhances delta- and kappa-opioid antinociception, but suppresses mu-opioid antinociception. Brain Res 1014:22-33.
3. Larson P, H Kronenberg, S Melmed and K Polonsky. (2002). Williams Textbook of Endocrinology. Saunders, Philadelphia, PA.
4. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
5. Porayette P, MJ Gallego, MM Kaltcheva, SV Meethal and CS Atwood. (2007). Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin. Biochem Biophys Res Commun 364:522-527.
6. Li X, and S Zhang. (2006). In vitro differentiation of neural precursors from human embryonic stem cells. Methods Mol Biol 331:169-177.
7. Corbett AD, MG Gillan, HW Kosterlitz, AT McKnight, SJ Paterson and LE Robson. (1984). Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. Br J Pharmacol 83:271-279.
8. Paterson SJ, AD Corbett, MG Gillan, HW Kosterlitz, AT McKnight and LE Robson. (1984). Radioligands for probing opioid receptors. J Recept Res 4: 143-154.
9. Cemerikic B, R Schabbing and MS Ahmed. (1992). Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue. Peptides 13:897-903.
10. Fiala C and K Gemzel-Danielsson. (2006). Review of medical abortion using mifepristone in combination with a prostaglan-din analogue. Contraception 74:66-86.
11. Stein DG, DW Wright and AL Kellermann (2008). Does progesterone have neuroprotective properties? Ann Emerg Med 51:164-172.
12. Heikinheimo O, R Kekkonen and P Lahteenmaki. (2003). The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. Contraception 68:421-426.
13. Exelgyn and Laboratories (February 2006). "Mifegyne UK Summary of Product Characteristics (SPC)" Retrieved on September 9, 2008; http://emc.medicines.org.uk/emc/assets/c/ html/displaydoc.asp?documentid=617).
14. Gu G and RB Simerly. (1994). Hormonal regulation of opioid peptide neurons in the anteroventral periventricular nucleus. Horm Behav 28:503-511.
15. Dufourny L, A Caraty, IJ Clarke, JE Robinson and DC Skinner. (2005). Progesterone-receptive beta-endorphin and dynorphin B neurons in the arcuate nucleus project to regions of high gonadotropin-releasing hormone neuron density in the ovine preoptic area. Neuroendocrinology 81:139-149.